Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT05920759 · ClinicalTrials.gov registry record · NA
Sex-specific Effect of Restricted Sleep on Brain Health
A NA study, sponsored by University of Missouri-Columbia.
- Completed
- Registry status
- NA
- Development phase
- 16
- Enrollment target
NCT05920759 is a NA study that has completed, run by University of Missouri-Columbia. The registered enrollment target is 16 participants.
The verdict
NCT05920759, a NA study, has completed, sponsored by University of Missouri-Columbia.
- COMPLETED
- Registry status
- NA
- Development phase
- 16 participants
- Enrollment target
Study Summary
The goal of this clinical trial is to compare the impact of restricted sleep on brain blood health in healthy men and women. The main question\[s\] it aims to answer are: * Whether morning cerebral blood flow velocity is greater following a night of normal sleep compared to restricted sleep * Whether the effect of sleep restriction on cerebral blood flow will be greater in males compared to females Participants will complete one 1-hour screening visit and two 2.5-hour study visits. Study visits will be conducted on two separate days.
Interventions
- DIAGNOSTIC_TEST Cerebral blood flow
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 16 participants |
| Start Date | 2023-10-01 |
| Est. Completion | 2025-09-01 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT05920759
The ClinicalTrials.gov registry entry for NCT05920759 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 16 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Missouri-Columbia, which has 291 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 1 intervention - of which Cerebral blood flow is the first listed.
NCT05920759 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT05920759 about?
NCT05920759 is a clinical study titled "Sex-specific Effect of Restricted Sleep on Brain Health". The goal of this clinical trial is to compare the impact of restricted sleep on brain blood health in healthy men and women. The main question\[s\] it aims to answer are: * Whether morning cerebral blood flow velocity is greater following a night of normal sleep compared to restricted sleep * Wheth...
What is the current status of trial NCT05920759?
This trial is currently completed. It is a NA study. The enrollment target is 16 participants. The study started on 2023-10-01. Estimated completion is 2025-09-01.
What interventions are being tested in trial NCT05920759?
The interventions under investigation include: Cerebral blood flow (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT05920759?
This trial is sponsored by University of Missouri-Columbia, which has 291 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.